Download PDF
Hamostaseologie 1985; 05(02): 54-64
DOI: 10.1055/s-0038-1655101
Originalarbeiten
Schattauer GmbH

Blutungskomplikationen während und nach Einsatz der Herz-Lungen-Maschine

Pathophysiologie, Diagnostik, Prävention und Therapie
D. Heinrich
1   Zentrum für Innere Medizin (Gesch. Direktor: Prof. Dr. Dr. h.c.H.-G. Lasch), der Klinik für Herz-und Gefäßchirurgie und der Klinischen Forschungsgruppe für Blutgerinnung und Thrombose, Max-Planck-Gesellschaft, Klinikum der Justus-Liebig-Universität Gießen
,
Th. Eckhardt
1   Zentrum für Innere Medizin (Gesch. Direktor: Prof. Dr. Dr. h.c.H.-G. Lasch), der Klinik für Herz-und Gefäßchirurgie und der Klinischen Forschungsgruppe für Blutgerinnung und Thrombose, Max-Planck-Gesellschaft, Klinikum der Justus-Liebig-Universität Gießen
,
R. Höge
1   Zentrum für Innere Medizin (Gesch. Direktor: Prof. Dr. Dr. h.c.H.-G. Lasch), der Klinik für Herz-und Gefäßchirurgie und der Klinischen Forschungsgruppe für Blutgerinnung und Thrombose, Max-Planck-Gesellschaft, Klinikum der Justus-Liebig-Universität Gießen
,
G. Müller-Berghaus
1   Zentrum für Innere Medizin (Gesch. Direktor: Prof. Dr. Dr. h.c.H.-G. Lasch), der Klinik für Herz-und Gefäßchirurgie und der Klinischen Forschungsgruppe für Blutgerinnung und Thrombose, Max-Planck-Gesellschaft, Klinikum der Justus-Liebig-Universität Gießen
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • LITERATUR

  • 1 Addonizio jr. V. P, Macarak J, Nicolaou K. C, Edmunds Jr L. H, Colman R. W. Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation. Blood 53: 1033-1042 1979;
    PubMedGoogle Scholar
  • 2 Addonizio jr. V. P, Smith J. B, Strauss III J. F, Colman R. W, Edmunds Jr L. H. Thromboxane synthesis and platelet secretion during cardiopulmonary bypass with bubble oxygenator. J. Thorac. Cardiovasc. Surg. 79: 91-96 1980;
    PubMedGoogle Scholar
  • 3 Addonizio jr. V. P, Strauss III J. F, Colman R. W, Edmunds Jr L. H. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator. J. Thorac. Cardiovasc. Surg. 77: 119-126 1979;
    PubMedGoogle Scholar
  • 4 Addonizio V. P, Strauss III J. F, Macarak E. J, Colman R. W, Edmunds Jr L. H. Preservation of platelet number and function with prostaglandin E1 during total cardiopulmonary bypass in rhesus monkeys. Surgery 83: 619-625 1978;
    PubMedGoogle Scholar
  • 5 Bachmann F, McKenna R, Cole E. R, Najafi E. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J. Thorac. Cardiovasc. Surg. 70: 76-85 1975;
    PubMedGoogle Scholar
  • 6 Bachmann F, McKenna R, Whitaker B. Abnormale Thrombozytenfunktion nach Herzchirurgie mit extrakorporaler Zirkulation. Schweiz. Med. Wschr. 104: 1374-1375 1974;
    PubMedGoogle Scholar
  • 7 Bianco C, Eden A, Cohn Z. A. The induction of macrophage spreading: Role of coagulation factors and the complement system. J. Exp. Med. 144: 1531-1544 1976;
    CrossrefPubMedGoogle Scholar
  • 8 Bick R. L. Alterations of hemostasis associated with cardiopulmonary bypass: Pathophysiology, prevention, diagnosis and management. Semin. Thromb. Hemostas. 03: 59-82 1976;
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Bick R. L, Arbegast N, Crawford L. Hemostatic defects induced by cardiopulmonary bypass. Vase. Surg. 09: 228-243 1975;
    PubMedGoogle Scholar
  • 10 Blombäck M, Norén I, Senning A. Coagulation disturbances during extracorporeal circulation and the postoperative period. Acta Chir. Scand 127: 433-445 1964;
    PubMedGoogle Scholar
  • 11 Brash J. L. Hydrophobic polymer surfaces and their interaction with blood. Ann. NY. Acad. Sci. 283: 356-370 1977;
    CrossrefPubMedGoogle Scholar
  • 12 Brash J. L, Davidson V. J. Adsorption on glass and polyethylene from solutions of fibrinogen and albumin. Thromb. Res. 09: 249-259 1976;
    CrossrefPubMedGoogle Scholar
  • 13 Brismar B, Gullbring B, Oldsson P. Effects of stored and fresh blood transfusions on postoperative pulmonary function. Clinical study on patients following extracorporeal circulation in association with aortic valve surgery. Europ. Surg. Res. 10: 153-164 1978;
    CrossrefPubMedGoogle Scholar
  • 14 Brögli H. Der Mechanismus des sogenannten »Heparin-Rebound« nach extrakorporalem Kreislauf. Thromb. Diathes. Haemorrh. 13: 401-417 1965;
    PubMedGoogle Scholar
  • 15 Büttner W, Popöv-Cenic S, Müller N, Kladetzky R. G. Neutralization of heparin after extracorporeal circulation. Anaesthesist. 24: 299-305 1975;
    PubMedGoogle Scholar
  • 16 Bull B. S, Huse W. M, Brauer F. S, Korpmann R. A. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J. Thorac. Cardiovasc. Surg. 69: 685-689 1975;
    PubMedGoogle Scholar
  • 17 Chesebro J. H, Clements J. P, Fu-ster V, Elveback L. R, Smith H. C, Bardsley W. T, Fey R. L, Holmes Jr D. R, Vlietstra E, Pluth J. R, Wallace R. B, Puga F. J, Orszulak T. A, Piehler J. M, Schaff H. V, Danielson G. K. A platelet-inhibitor-drug trial in coronary-artery bypass operations. Benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. New Engl. J. Med. 307: 73-78 1982;
    CrossrefPubMedGoogle Scholar
  • 18 Cohen J. A. Activated clotting time method for control of heparin is reliable during cardiopulmonary bypass. Anesthesiology 60: 121-124 1984;
    CrossrefPubMedGoogle Scholar
  • 19 Cohen L. H, Fosberg A. M, Anderson W. P, Collins Jr J. J. The effects of phlebotomy, hemodilution and autologous transfusion on systemic oxygenation and whole blood utilization in open-heart surgery. Chest 68: 283-295 1975;
    CrossrefPubMedGoogle Scholar
  • 20 Craddock P. R, Fehr J, Dalmasso A. P, Brigham K. L, Jacob H. S. Hemodialysis leukopenia: pulmonary vascular leucostasis resulting from complement activation by dialyzer cellophane membranes. J. Clin. Invest 59: 879-888 1977;
    CrossrefPubMedGoogle Scholar
  • 21 Davey F. R, Parker F. B. Delayed hemostatic changes following cardiopulmonary bypass. Amer. J. Med. Sci. 27H2: 171-178 1976;
    PubMedGoogle Scholar
  • 22 Davies G. C, Sobel M, Salzman E. W. Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass. Circulation 61: 808-814 1980;
    CrossrefPubMedGoogle Scholar
  • 23 De Vries S. E, von Creveld S, Croen P, Muller E, Wettermark M. Studies on the coagulation of the blood in patients treatment with extracorporeal circulation. Thromb. Diath. Haemorrh. 05: 426-431 1961;
    PubMedGoogle Scholar
  • 24 da Silva Dias W, Eisele J. W, Lepton I. H. Complement as a mediator of inflammation. III. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C3. J. Exp. Med. 126: 1027-1048 1967;
    CrossrefPubMedGoogle Scholar
  • 25 Dierich M. P, Wilhelmi D, Till G. Essential role of surface-bound chemoattractant in leukocyte migration. Nature 270: 351-352 1977;
    CrossrefPubMedGoogle Scholar
  • 26 DiScipio R. G. The activation of the alternative pathway C3 convertase by human plasma kallikrein. Immunology 45: 587-595 1982;
    PubMedGoogle Scholar
  • 27 Ditter H, Heinrich D, Matthias F. R, Wagner W-L, Sellmann-Richter R, Hehrlein F. W. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of ß-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin Fla and heparin. Thromb. Res. 32: 393-408 1983;
    CrossrefPubMedGoogle Scholar
  • 28 Dutton R. C, Edmunds Jr L. H, Hutchinson J. C, Roe B. B. Platelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters. J. Thorac. Cardiovasc. Surg. 67: 258-265 1974;
    PubMedGoogle Scholar
  • 29 Edmunds jr. L. H, Ellison N, Colman R. W, Niewiarowski S, Rao A. K, Addonizio Jr V. P, Stephenson L. W, Edie R. N. Platelet function during cardiac operation: comparison of membrane and bubble oxygenators. J. Thorac. Cardiovasc. Surg. 83: 805-812 1982;
    PubMedGoogle Scholar
  • 30 Evans E. A, Wellington J. S. Emboli associated with cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 48: 323-330 1964;
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Faichney A, Davidson K. G, Wheatley D. J, Davidson J. F, Walker I. D. Prostacyclin in cardiopulmonary bypass operations. J. Thorac. Cardiovasc. Surg. 84: 601-608 1982;
    PubMedGoogle Scholar
  • 32 Friesen R. H, Clement A. J. Individual responses to heparinization for extracorporal circulation. J. Thorac. Cardiovasc. Surg. 72: 875-879 1976;
    PubMedGoogle Scholar
  • 33 Götze O, Bianco C, Cohn Z. A. The induction of macrophage spreading by Factor B of the properdin system. J. Exp. Med. 149: 372-386 1972;
    PubMedGoogle Scholar
  • 34 Goldsmith G. H, Saito H, Ratnoff O. S. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments. J. Clin. Invest 78: 54-60 1978;
    PubMedGoogle Scholar
  • 35 Gollub S. Heparin rebound in open-heart surgery. Surg. Gynecol. Obstet. 124: 337-346 1967;
    PubMedGoogle Scholar
  • 36 Griffin J. H. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII. Proc. Natl. Acad. Sci. USA. 75: 1998-2002 1978;
    CrossrefPubMedGoogle Scholar
  • 37 Griffin J. H, Cochrane C. G. Recent advances in the understanding of contact activation reactions. Sem. Thrombos. Hemost. 05: 254-273 1979;
    PubMedGoogle Scholar
  • 38 Hallowell P, Bland J. H, Buckley M. J, Loewenstein E. Transfusion of fresh autologous blood in open-heart surgery: A method for reducing bank blood requirements. J. Thorac. Cardio vase. Surg. 64: 941-948 1972;
    PubMedGoogle Scholar
  • 39 Harker L. A, Malpass T. W, Branson H. E, Hessel E. A, Slichter S. J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective a-granule release. Blood 56: 824-834 1980;
    PubMedGoogle Scholar
  • 40 Harker L. A, Sherrill J, Slichter S. J. Platelet and fibrinogen consumption in man. New Engl. J. Med. 287: 999-1005 1972;
    CrossrefPubMedGoogle Scholar
  • 41 Hatano R, Yamada T, Tsukuura T, Sunamori M. A role of extracorporeal circuit in the post-perfusion thrombocytopenia: A scanning electron microscopy observation. Jpn. J. Surg. 05: 234-245 1975;
    CrossrefPubMedGoogle Scholar
  • 42 Heiden D, Mielke C. H, Rodvien R, Hill J. D. Platelets, hemostasis, and thromboembolism during treatment of acute respiratory insufficiency with extracorporeal membrane oxygenation. J. Thorac. Cardiovasc. Surg. 70: 644-655 1975;
    PubMedGoogle Scholar
  • 43 Heimark R. L, Kurachi K, Fujikawa K, Davie E. W. Surface activation of blood coagulation, fibrinolysis and kinin formation. Nature 286: 456-560 1980;
    CrossrefPubMedGoogle Scholar
  • 44 Heinrich D, Simon W, Türschmann W, Wüsten B, Roka L, Hehrlein F. W. Veränderungen des Hämostasesystems unter den Bedingungen der extrakorporalen Zirkulation bei aortokoronaren Venenbypassoperationen. In: Mikrozirkulation und Prostaglandinstoffwechsel. G. Blümel, S. Haas (Hrsg.). Schattauer. Stuttgart; New York: 1981: 195-198.
    Google Scholar
  • 45 Heinrich D, Thilo-Körner D. G. S, Roka L. Die Bedeutung des Gefäßendothels für die Regulation der Fibrinolyse. Drug. Res. 33: 1375-1378 1983;
    PubMedGoogle Scholar
  • 46 Hennessy V. L, Hicks R. E, Niewia-rowski S, Edmunds L. H, Colman R. W. Function of human platelets during extracorporeal circulation. Amer. J. Physiol. 232: 622-628 1977;
    PubMedGoogle Scholar
  • 47 Henson P. M, Hollister J. R, Musson R. A, Webster R. O, Spears P, Henson J. E, McCarthy K. M. Inflammation as a surface phenomenon: Initiation of inflammatory processes by surface-bound immunologic components. Adv. Inflam. Res. 01: 341-350 1979;
    PubMedGoogle Scholar
  • 48 Hill J. D, Aguilar M. J, Baranco A, DeLanerolle P, Gerbode F. Neuropathological manifestations of cardiac surgery. Ann. Thorac. Surg. 07: 409-419 1969;
    CrossrefPubMedGoogle Scholar
  • 49 Holemans R, Vermylen C, Ver-straete M. Disappearence of factor V activity after incubation of plasma with heparin or heparinoids. Thromb. Diathes. Haemorrh. 04: 303-322 1960;
    PubMedGoogle Scholar
  • 50 Housman L. B. Blood conservation during cardiopulmonary bypass. In: Pathophysiology and Techniques of Cardiopulmonary Bypass. Vol. 1. Utley J. R. (Ed.) Williams and Wilkins; Baltimore, London: 1982: 120-127.
    Google Scholar
  • 51 Hoylaerts M, Rijken D. C, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J. Biol. Chem. 257: 2912-2919 1982;
    PubMedGoogle Scholar
  • 52 Huglie T. E. Complement factors and inflammation: Effects of a-thrombin on components C3 and C5. In: Chemistry and Biology of Thrombin. Lundblad R. L, Fenton J. W, Mann K. G. (Eds.) Ann Arbor Science; Michigan: 1977: 345-360.
    Google Scholar
  • 53 Hyun B. H, Pence R. E, Davila J. C, Butcher J, Custer R. P. Heparin rebound phenomenon in extracorporeal circulation. Surg. Gynecol. Obstet. 115: 191-198 1962;
    PubMedGoogle Scholar
  • 54 Kaplan A. P, Castellino F. J, Collen D, Wiman B, Taylor Jr F. B. Molecular mechanisms of fibrinolysis in man. Thromb. Haemost. 39: 263-283 1978;
    Article in Thieme ConnectPubMedGoogle Scholar
  • 55 Levai de M. R, Hill J. D, Mielke C. H, Macur M. F, Gerbode F. Blood platelets and extracorporeal circulation. Kinetic studies on dogs on cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 69: 144-151 1975;
    PubMedGoogle Scholar
  • 56 Longmore D. B, Bennett J. G, Gueirrara D, Smith M, Bunting S, Mon-cada S, Reed P, Read N. G, Vane J. R. Prostacyclin: A solution to some problems of extracorporeal circulation. Experiment in greyhounds. Lancet I: 1002-1005 1979;
    PubMedGoogle Scholar
  • 57 Longemore D. B, Bennett J. G, Hoyle P. M, Smith M. A, Gregory A, Osivand T, Jones W. A. Prostacyclin administration during cardiopulmonary bypass in man. Lancet. I: 800-804 1981;
    PubMedGoogle Scholar
  • 58 Marby C. D, Read R. C, Thompson B. W, Williams G. D, White H. J. Identification of heparin resistance during cardiac and vascular surgery. Arch. Surg. 114: 129-134 1979;
    CrossrefPubMedGoogle Scholar
  • 59 McKenna R, Bachmann F, Whittaker B, Gilson J. R, Weinberg M. The hemostatic mechanism after open-heart surgery. Frequency of abnormal platelet functions during and after extracorporeal circulation. J. Thorac, Cardiovasc. Surg. 70: 298-308 1975;
    Article in Thieme ConnectPubMedGoogle Scholar
  • 60 McKenzie F. N, Dhall D. P, Arfors K-E, Nordlund S, Mathson N. A. Blood platelet behaviour during and after open-heart surgery. Brit. Med. J. 02: 795-798 1969;
    CrossrefPubMedGoogle Scholar
  • 61 Malpass T, Hanson S. R, Savage B, Hessel E. A, Harker L. A. Prevention of aquired transient defect in platelet plug formation by infused prostacyclin. Blood 57: 736-740 1981;
    PubMedGoogle Scholar
  • 62 Mammen E. F. Natural proteinase inhibitors in extracorporal circulation. Ann. N.Y. Acad. Sci. 146: 754-762 1968;
    CrossrefPubMedGoogle Scholar
  • 63 Mandle jr. R. J, Colman R. W, Kaplan A. P. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc. Natl. Acad. Sci. USA. 73: 4179-4183 1976;
    CrossrefPubMedGoogle Scholar
  • 64 Mandle jr. R. J, Kaplan A. P. Hageman factor substrates. Human plasma prekallikrein: Mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. J. Biol. Chem. 252: 6097-6104 1977;
    PubMedGoogle Scholar
  • 65 Mason K. G, Hall L. E, Lamoy R. E, Wright C. B. Evaluation of blood filters: Dynamics of platelets and platelet aggregates. Surgery 77: 235-240 1975;
    PubMedGoogle Scholar
  • 66 Merill E. W, Salzman E. W. Properties of materials affecting the behavior of blood at their surfaces. In: Sawyer P. N, Kaplitt M. J. (Eds.): Vascular Grafts. Appleton-Century-Croffts. New York: 1978: 119-129.
    Google Scholar
  • 67 Mielke C. H, de Levai M. R, Hill J. D, Macur M. F, Gerbode F. Drug influence on platelet loss during extracorporeal circulation. J. Thorac. Cardiovasc. Surg. 66: 845-854 1973;
    PubMedGoogle Scholar
  • 68 Moriau M, Masure R, Horlet A, Debeys C, Chalant C. Hemostasis disorders in open-heart surgery with extracorporeal circulation. Importance of the platelet function and heparin neutralization. Vox Sang. 32: 41-51 1977;
    PubMedGoogle Scholar
  • 69 Müller N, Popov-Cenic S, Büttner W, Kladetzky R. G, Egli H. Studies of fibrinolytic and coagulation factors during open-heart surgery. II. Postoperative bleeding tendency and changes in the coagulation system. Thromb. Res. 07: 589-598 1975;
    CrossrefPubMedGoogle Scholar
  • 70 Müller-Eberhard H. J. Complement. Ann. Rev. Biochem. 44: 697-724 1975;
    CrossrefPubMedGoogle Scholar
  • 71 Mustard J. F, Packham M. A. Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol. Rev. 23: 97-187 1970;
    PubMedGoogle Scholar
  • 72 Naeye R. L. Thrombotic state after a hemorrhagic diathesis: a possible complication of therapy with epsilon aminocapronacid. Blood 19: 694-701 1962;
    PubMedGoogle Scholar
  • 73 Nuutinen L. S, Mononen P. Dipyridamol and thrombocyte count in open-heart surgery. J. Thorac. Cardiovasc. Surg. 70: 707-711 1975;
    PubMedGoogle Scholar
  • 74 Petschek H, Adamis D, Kantro-witz A. R. Stagnation flow thrombus formation. Trans. Am. Soc. Artif. Intern. Organs 14: 256-260 1968;
    PubMedGoogle Scholar
  • 75 Porter J. M, Silver D. Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 56: 869-878 1968;
    PubMedGoogle Scholar
  • 76 Ratnoff O. D, Naff G. B. The conversion of Cls to Cl esterase by plasmin and trypsin. J. Exp. Med. 125: 337-358 1967;
    CrossrefPubMedGoogle Scholar
  • 77 Ratnoff O. D, Saito H. Amidolytic properties of single-chain activated Hageman factor. Proc. Natl. Acad. Sci. USA. 76: 1461-1463 1979;
    CrossrefPubMedGoogle Scholar
  • 78 Roche J. K, Stengele J. M. Open-heart surgery and the demand for blood. JAMA. 225: 1516-1521 1973;
    CrossrefPubMedGoogle Scholar
  • 79 Rossi-Ferrini P. Coagulation problems related to open-heart surgery. Int. Anesthesiol. Clin. 14: 103-122 1976;
    CrossrefPubMedGoogle Scholar
  • 80 Salzman E. W. Nonthrombogenic surfaces: Critical review. Blood 38: 509-523 1971;
    PubMedGoogle Scholar
  • 81 Sandiford F. M, Chiarello L, Hallman G. L, Cooley D. A. Aorto-coronary bypass in Jehovah’s Witnesses: Report of 36 patients. J. Thorac. Cardiovasc. Surg. 68: 1-7 1974;
    Article in Thieme ConnectPubMedGoogle Scholar
  • 82 Schaff H. V, Hauer J. M, Bra-wiey R. K. Auto transfusion in cardiac surgical patients after operation. Surgery 84: 713-718 1978;
    PubMedGoogle Scholar
  • 83 Signori E. E, Penner J. A, Kahn D. R. Coagulation defects and bleeding in open-heart surgery. Ann. Thorac. Surg. 08: 521-529 1969;
    CrossrefPubMedGoogle Scholar
  • 84 Solis R. T, Noon G. P, Beall Jr A. C, DeBakey M. E. Particulate microembolism during cardiac operation. Ann. Thorac. Surg. 17: 332-344 1974;
    CrossrefPubMedGoogle Scholar
  • 85 Taubman S. B, Lepow I. H. Cleavage of human Cls by human lysosomal enzymes, plasmin, and trypsin. Immunochemistry 08: 951-961 1971;
    CrossrefPubMedGoogle Scholar
  • 86 Tector A. J, Gabriel R. P, Mate-ricka W. E, Oparah S. S, Flemm R. J, Lepley Jr D. Reduction of blood usage in open-heart surgery. Chest 70: 454-457 1976;
    CrossrefPubMedGoogle Scholar
  • 87 Thompson R. E, Mandle Jr R. J, Kaplan A. P. Association of factor XI and high-molecular-weight kininogen in human plasma. J. Clin. Invest 60: 1376-1380 1977;
    CrossrefPubMedGoogle Scholar
  • 88 Venerröd A. M, Laake K. Prekallikrein and plasminogen proactivator: absence of plasminogen proactivator in Fletcher factor deficient plasma. Thromb. Res. 08: 519-522 1976;
    CrossrefPubMedGoogle Scholar
  • 89 Verska J. J, Lonser E. R, Brewer L. A. Predisposing factors and management of hemorrhage following open-heart surgery. J. Cardiovasc. Surg. 13: 361-368 1972;
    PubMedGoogle Scholar
  • 90 Vroman L, Adams A. L. Identification of rapid changes at plasma-solid interfaces. J. Biomed. Mater. Res. 03: 43-67 1969;
    CrossrefPubMedGoogle Scholar
  • 91 Vroman L, Adams A. L, Klings M. Interactions among human blood proteins at interfaces. Fed. Proc. 30: 1494-1502 1971;
    PubMedGoogle Scholar
  • 92 Wagstaffe J. G, Clarke A. D, Jackson P. W. Reduction of blood loss by restoration of platelet levels using fresh autologous blood after cardiopulmonary bypass. Thorax. 27: 410-414 1972;
    CrossrefPubMedGoogle Scholar
  • 93 Walker J. D, Davidson J. F, Faich-ney A, Wheatley D. J, Davidson K. G. A double blind study of prostacyclin in cardiopulmonary bypass surgery. Brit. J. Haematol. 49: 415-423 1981;
    CrossrefPubMedGoogle Scholar
  • 94 Wandall H. H, Silvertsen U. The puzzle of blood platelets in extracorporeal circulation. Comments based on recirculation experiments. Scand. J. Thorac. Cardiovasc. Surg. 09: 140-143 1975;
    PubMedGoogle Scholar
  • 95 Watkins W. D, Peterson W. B, Kong D. L, Kono K, Buckley M. J, Levine F. H, Philbin D. M. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow. J. Thorac. Cardiovasc. Surg. 84: 250-256 1982;
    Article in Thieme ConnectPubMedGoogle Scholar
  • 96 Webster R. O, Zanolari B, Henson P. M. Neutrophil chemotaxis in response to surface-bound human C5a. Exp. Cell. Res. 129: 55-62 1980;
    CrossrefPubMedGoogle Scholar
  • 97 Wiggins R. C, Bouma B. N, Cochrane C. G, Griffin J. H. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation factor XI and prekallikrein. Proc. Natl. Acad. Sci. USA. 74: 4636-4640 1977;
    CrossrefPubMedGoogle Scholar
  • 98 Wiggins R. C, Giclas P. C, Henson P. M. Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit. J. Exp. Med. 153: 1391-1404 1981;
    CrossrefPubMedGoogle Scholar
  • 99 Yeh jr. T, Shelton L, Yeh T. J. Blood loss and bank blood requirement in coronary bypass surgery. Ann. Thorac. Surg. 26: 11-16 1978;
    CrossrefPubMedGoogle Scholar
  • 100 Young J. A, Kisker C. T, Doty D. B. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. Ann. Thorac. Surg. 26: 231-240 1978;
    CrossrefPubMedGoogle Scholar